TOX通过阻止PD1降解促进肝细胞癌中抗肿瘤CD8+ T细胞耗竭
该研究探讨TOX在肝细胞癌CD8+ T细胞耗竭中的作用。研究发现TOX在耗竭的CD8+ T细胞中上调,下调TOX可抑制肿瘤生长、增加CD8+ T细胞浸润、缓解耗竭并改善抗PD1反应。机制上,TOX与PD1结合促进其内吞再循环,维持细胞表面PD1高表达。
要点
- TOX在肝细胞癌耗竭CD8+ T细胞中上调。
- 下调TOX可增强抗肿瘤免疫并与抗PD1治疗协同。
- TOX通过促进PD1内吞再循环维持表面高表达。
核心结论
- TOX通过调控PD1内吞再循环促进肝细胞癌CD8+ T细胞耗竭,下调TOX与抗PD1治疗有协同作用。
研究设计与样本
- 研究采用流式分选全功能、部分耗竭和严重耗竭的肿瘤浸润CD8+ T细胞进行转录组测序,并在小鼠HCC模型和HCC患者来源异种移植小鼠模型中研究TOX下调或过表达CD8+ T细胞的抗肿瘤功能。
主要发现
- TOX在肝细胞癌耗竭CD8+ T细胞中上调。
- 下调CD8+ T细胞中TOX可抑制肿瘤生长、增加CD8+ T细胞浸润、缓解耗竭并改善抗PD1反应。
- TOX与胞质中PD1结合,促进PD1内吞再循环,维持细胞表面PD1高表达。
- 外周CD8+ T细胞中TOX高表达与较差抗PD1反应和预后相关。
临床怎么用
- 下调CD8+ T细胞中TOX表达与抗PD1治疗协同,为癌症免疫治疗提供潜在策略。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The thymocyte selection-associated high mobility group box protein (TOX) plays a vital role in T cell development and differentiation, however, its role in T cell exhaustion was unexplored. Here, we aim to investigate the role of TOX in regulating the antitumor effect of CD8+ T cells in hepatocellular carcinoma. METHODS: Fully functional, partially and severely exhausted tumor-infiltrating CD8+ T cells were sorted by flow cytometry and subjected to transcriptome sequencing analysis. Upregulated TOX expression was validated by flow cytometry. The antitumor function of CD8+ T cells with TOX downregulation or overexpression was studied in a mouse HCC model and HCC patient-derived xenograft mouse model. Transcriptome sequencing analysis was performed in TOX-overexpressing and control CD8+ T cells. The mechanism underlying the TOX-mediated regulation of PD1 expression was studied by laser confocal detection, immune co-precipitation and flow cytometer. RESULTS: TOX was upregulated in exhausted CD8+ T cells in hepatocellular carcinoma. TOX downregulation in CD8+ T cells inhibited tumor growth, increased CD8+ T cell infiltration, alleviated CD8+ T cell exhaustion and improved the anti-PD1 response of CD8+ T cells. The mechanism behind this involved the binding of TOX to PD1 in the cytoplasm, which facilitated the endocytic recycling of PD1, thus maintaining abundant PD1 expression at the cell surface. High expression of TOX in peripheral CD8+ T cells correlated with poorer anti-PD1 responses and prognosis. CONCLUSIONS: TOX promotes CD8+ T cell exhaustion in hepatocellular carcinoma by regulating endocytic recycling of PD1. Downregulating TOX expression in CD8+ T cells exerts synergistic effects with anti-PD1 therapy, highlighting a promising strategy for cancer immunotherapy. LAY SUMMARY: Abundant TOX expression in CD8+ T cells impairs their antitumor function in hepatocellular carcinoma. Mechanically, TOX reduces PD1 degradation and promotes PD1 translocation to the cell surface in CD8+ T cells, thus maintaining high PD1 expression at the cell surface. Downregulating TOX expression improves the antitumor function of CD8+ T cells, which shows the synergetic role of anti-PD1 therapy, highlighting a promising strategy for enhancement of cancer immunotherapy.
引用
- Wang X, He Q, Shen H, et al. TOX promotes the exhaustion of antitumor CD8+ T cells by preventing PD1 degradation in hepatocellular carcinoma. J Hepatol. 2019. PMID: 31173813. doi:10.1016/j.jhep.2019.05.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。